Skip to content
healthcare.dev

METHOTREXATE

NDC 62332-712, methotrexate, injection, solution, from Alembic Pharmaceuticals Inc..

Product NDC
62332-712
Status
Listed
Labeler
Alembic Pharmaceuticals Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA220225
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62332-712 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHOTREXATE SODIUM25 mg/mL

Pharmacologic classes

Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]

Package NDCNDC-11Package
62332-712-01623320712011 VIAL, SINGLE-DOSE in 1 CARTON (62332-712-01) / 40 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a63364d5-4dfa-49d7-8a5e-c8959ae1d37a

Use it

Look up 62332-712 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62332-712 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62332-712. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.